By Dean Seal
Shares of Teladoc Health slumped after the company logged a wider fourth-quarter loss than analysts had expected and provided tepid guidance for 2025.
The stock was down 18% at $9 in early trading. Shares are now teetering into negative territory year-to-date. They were trading at $15.16 this time a year ago.
The virtual care company reported a loss of 28 cents a share for the fourth quarter. Analysts polled by FactSet had been expecting a smaller 26-cent per-share loss. Revenue of $640.5 million for the quarter was $1 million higher than projected.
Teladoc guided for $2.47 billion to $2.58 billion in revenue in 2025, along with a net loss of 50 cents to $1.10 a share. The midpoint of those ranges were weaker than analyst projections, which have since been adjusted to reflect lower sales and a wider loss, according to FactSet.
The current year is a known transition year for Teladoc, and the stock decline likely reflects that guidance is heavily weighted toward the back-end of the year, Stifel analysts said in a research note.
"We expect TDOC's stock price to remain volatile given the absence of near-term catalysts and a meaningful short interest," the analysts said.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
February 27, 2025 10:00 ET (15:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.